CS
China Shineway Pharmaceutical Group Limited
CSWYF · OTC
$1.00 +0.00% (+$0.00)
Market Cap ¥5.08B
P/E Ratio 5.35x
Div. Yield 7.73%
ROE 12.39%
Bulios Fair Price
$1.43
42.4% upside
Current Price
$1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CSWYF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
98 /100
Cheap PEG 0.41x
P/B 0.63x
P/FCF 5.21x
Growth
28 /100
Declining Rev. growth 8.02%
FCF growth 3.72%
Book val. growth 8.65%
Profitability
98 /100
Strong Net margin 30.30%
Op. margin 22.89%
FCF margin 31.07%
Quality
46 /100
Average ROE 12.39%
ROA 8.81%
Asset turnover 0.29x
Debt
100 /100
Low Current ratio 3.71x
Int. coverage 224.27x
Net debt/EBITDA -5.09x
Stability
64 /100
Moderate Rev. volatility 432.52%
EPS volatility 23.39%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CSWYF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zhenjiang Li
Employees
2,822
Headquarters
Shijiazhuang